subject: UMLS:C3491009

object_name: adult glioblastoma


subject: UMLS:C3491009

object_name: anaplastic astrocytoma

tested_intervention: unsure


subject: UMLS:C0919079

subject_name: TEMOZOLOMIDE, ORAL, 5 MG ADMINISTERED


subject: CHEBI:72564

subject_name: Temozolomide


subject: CHEBI:193615

object_name: intrahepatic cholangiocarcinoma


subject: CHEBI:193615

object_name: intrahepatic bile duct cancer


subject: CHEBI:60761

subject_name: Floxuridine


subject: CHEBI:60761


subject: CHEBI:51254

subject_name: AMOXICILLIN

object_name: pulmonary tuberculosis


subject: PUBCHEM.COMPOUND:2171


subject: CHEBI:2676

subject_name: Amoxicillin


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: CHEBI:53667

subject_name: Cefadroxil


subject: PUBCHEM.COMPOUND:520990


subject: CHEBI:3479


subject: CHEBI:51788

subject_name: faropenem


subject: CHEBI:63632

subject_name: Topotecan

object_name: ovarian cancer

tested_intervention: yes


subject: CHEBI:63632

object_name: ovarian neoplasm


subject: CHEBI:63632

object_name: ovarian carcinoma


subject: CHEBI:40021

subject_name: Tiratricol

object_name: Allan-Herndon-Dudley syndrome


subject: PUBCHEM.COMPOUND:198621


subject: UMLS:C0146607

subject_name: Triac Cold


subject: UMLS:C3712707

object_name: type 2 diabetes mellitus


subject: CHEBI:50853

subject_name: quantum dot


subject: CHEBI:58097

object_name: angina unstable


subject: CHEBI:17303

subject_name: Morphine


subject: CHEBI:107736

subject_name: Metoclopramide


subject: UNII:FU77B4U5Z0

subject_name: Ustekinumab

object_name: inflammatory bowel disease 1


subject: UNII:FU77B4U5Z0

object_name: Crohn disease


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: suppressor of tumorigenicity 3


subject: CHEBI:63605

object_name: cervical carcinoma


subject: CHEBI:63605

object_name: cervical adenocarcinoma


subject: CHEBI:63605

object_name: cervical adenosquamous carcinoma


subject: UMLS:C0879430


subject: UMLS:C0879430


subject: UMLS:C0879430


subject: UMLS:C0879430


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: hypertension


subject: CHEBI:46195

object_name: Hypertension, CTCAE


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: UMLS:C2917659


subject: CHEBI:35475

subject_name: non-steroidal anti-inflammatory drug


subject: CHEBI:35475


subject: UMLS:C0003211

subject_name: Anti-Inflammatory Agents, Non-Steroidal


subject: UMLS:C0003211


subject: UMLS:C3536840

subject_name: Nonsteroidal Anti-inflammatory Drug [EPC]


subject: UMLS:C3536840


subject: UNII:7XL5ISS668

subject_name: Adcetris

object_name: germ cell tumor


subject: UNII:7XL5ISS668

object_name: nongerminomatous germ cell tumor


subject: UNII:7XL5ISS668

object_name: embryonal carcinoma


subject: UNII:7XL5ISS668

object_name: embryonal carcinoma of the central nervous system


subject: UNII:7XL5ISS668

object_name: ovarian embryonal carcinoma


subject: UNII:7XL5ISS668

object_name: malignant testicular germ cell tumor


subject: UNII:7XL5ISS668

object_name: neoplasm of testis


subject: UNII:7XL5ISS668

object_name: testicular cancer


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UMLS:C1832035


subject: UNII:PQX0D8J21J

subject_name: Cetuximab


subject: UMLS:C0879636

subject_name: IMC C225


subject: PUBCHEM.COMPOUND:4056

subject_name: vitamin K2

object_name: Overweight and obesity


subject: UNII:71ANL51TLA

subject_name: Menaquinone 6


subject: PUBCHEM.COMPOUND:14236712

subject_name: Withanolide B


subject: PUBCHEM.COMPOUND:5280374


subject: CHEBI:28869

subject_name: Menadione


subject: UNII:12V8PA4WCH

subject_name: Menaquinone


subject: CHEBI:16374

subject_name: Menatetrenone


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: temporal arteritis


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Neck Carcinoma


subject: CHEBI:31355

object_name: head and neck neoplasm


subject: CHEBI:31355

object_name: head and neck cancer


subject: CHEBI:4672

subject_name: Docetaxel


subject: CHEBI:4672


subject: CHEBI:4672


subject: CHEBI:521033

subject_name: Dutasteride

object_name: benign prostatic hyperplasia


subject: UMLS:C2348756

subject_name: Testosterone Gel


subject: UMLS:C2348756

object_name: hypogonadism


subject: UNII:R8DG7T2D3A

subject_name: FERUMOXYTOL

object_name: AIDS dementia


subject: UNII:CLH5FT6412

subject_name: Ferumoxytol


subject: CHEBI:46726

subject_name: magnetite


subject: MESH:D007252

subject_name: Influenza Vaccines

object_name: Influenza-like illness


subject: MESH:D007252

object_name: Flu-Like Symptoms


subject: PUBCHEM.COMPOUND:44210114

subject_name: Lurasidone

object_name: schizophrenia


subject: CHEBI:177298

object_name: urothelial carcinoma


subject: CHEBI:177298

object_name: transitional cell carcinoma


subject: CHEBI:176844

subject_name: Niraparib


subject: CHEBI:176844


subject: CHEBI:8874

subject_name: Rivastigmine

object_name: Parkinson disease


subject: PUBCHEM.COMPOUND:11332179

subject_name: pasireotide

object_name: prolactinoma


subject: CHEBI:3286

subject_name: Cabergoline


subject: UNII:SE2KH7T06F

object_name: digestive system cancer


subject: UNII:SE2KH7T06F

object_name: ERBB2 Gene Mutation


subject: UMLS:C4287766


subject: UMLS:C4287766

object_name: Stomach cancer


subject: UMLS:C4287766

object_name: gastric cancer


subject: UMLS:C4287766


subject: CHEBI:61397

subject_name: Neratinib


subject: CHEBI:61397


subject: CHEBI:61397


subject: CHEBI:61397


subject: CHEBI:15422

subject_name: ATP

object_name: outcomes general quality of life


subject: CHEBI:15422

object_name: Perceived quality of life


subject: CHEBI:15422

object_name: Good quality of life


subject: CHEBI:15422

object_name: cancer


subject: CHEBI:15422

object_name: neoplasm


subject: CHEBI:15422

object_name: survival time


subject: CHEBI:15422

object_name: Encounter due to palliative care


subject: CHEBI:233644

subject_name: Senicapoc

object_name: interstitial lung disease 1


subject: CHEBI:233644

object_name: interstitial lung disease 2


subject: UNII:2P471X1Z11

subject_name: Omalizumab

object_name: Idiopathic angioedema


subject: UMLS:C0910794


subject: PUBCHEM.COMPOUND:92002593

subject_name: Ibritumomab

object_name: adult lymphoma


subject: PUBCHEM.COMPOUND:92002593

object_name: lymphoma


subject: PUBCHEM.COMPOUND:92002593

object_name: pediatric lymphoma


subject: UNII:4Q52C550XK

subject_name: Ibritumomab tiuxetan


subject: UNII:4Q52C550XK


subject: UNII:4Q52C550XK


subject: CHEBI:233411

subject_name: Zotiraciclib

object_name: Childhood Astrocytoma


subject: CHEBI:233411

object_name: glioma susceptibility 1


subject: CHEBI:233411

object_name: astrocytic tumor


subject: CHEBI:233411

object_name: astrocytoma


subject: CHEBI:233411

object_name: glioblastoma


subject: CHEBI:233411

object_name: Childhood Glioblastoma


subject: CHEBI:233411

object_name: adult glioblastoma


subject: CHEBI:233411

object_name: brain neoplasm


subject: CHEBI:233411

object_name: Adult Gliosarcoma


subject: CHEBI:233411

object_name: gliosarcoma


subject: CHEBI:233411

object_name: Childhood Gliosarcoma


subject: UMLS:C5421336


subject: UMLS:C5421336


subject: UMLS:C5421336


subject: UMLS:C5421336


subject: UMLS:C5421336


subject: UMLS:C5421336


subject: UMLS:C5421336


subject: UMLS:C5421336


subject: UMLS:C5421336


subject: UMLS:C5421336


subject: UMLS:C5421336


subject: UMLS:C3491009


subject: UMLS:C3491009


subject: UMLS:C3491009


subject: UMLS:C3491009


subject: UMLS:C3491009


subject: UMLS:C3491009


subject: UMLS:C3491009


subject: UMLS:C3491009


subject: UNII:9RV78Q2002

subject_name: Vedolizumab

object_name: Crohn disease


subject: UNII:9RV78Q2002

object_name: ulcerative colitis


subject: UNII:9RV78Q2002

object_name: inflammatory bowel disease 1


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UMLS:C1098513


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: relapsing-remitting multiple sclerosis


subject: UMLS:C0295415

subject_name: rituximab


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Hyperalgesia, Secondary


subject: CHEBI:3757

subject_name: Clonidine


subject: CHEBI:64312

subject_name: Memantine

object_name: Harmful pattern of substance use


subject: CHEBI:64312

object_name: substance abuse


subject: CHEBI:63610

subject_name: Misoprostol

object_name: postpartum hemorrhage


subject: CHEBI:63610

object_name: Post-partum hemorrhage


subject: CHEBI:143719

subject_name: H. influenzae type B capsular polysaccharide

object_name: poliomyelitis


subject: CHEBI:143719

object_name: diphtheria


subject: CHEBI:143719

object_name: tetanus


subject: UMLS:C4548849

object_name: Kinetic tremor


subject: CHEBI:50169

subject_name: Brexanolone


subject: UMLS:C3641122

object_name: gastroesophageal cancer


subject: UMLS:C3641122

object_name: pancreatic adenocarcinoma


subject: UMLS:C3641122

object_name: colorectal cancer


subject: UMLS:C3641122

object_name: colorectal carcinoma


subject: UMLS:C3641122

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C3641122

object_name: Childhood Breast Carcinoma


subject: UMLS:C3641122

object_name: breast carcinoma


subject: UMLS:C3641122

object_name: breast cancer


subject: UMLS:C3641122

object_name: lung cancer


subject: UMLS:C3641122

object_name: lung neoplasm


subject: UMLS:C3641122

object_name: lung carcinoma


subject: UMLS:C3641122

object_name: melanoma


subject: CHEBI:90227

subject_name: Selumetinib

object_name: Neck Carcinoma


subject: CHEBI:90227

object_name: biliary tract cancer


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227


subject: CHEBI:90227

object_name: liver carcinoma


subject: UNII:QEN1X95CIX

subject_name: Tremelimumab


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UNII:QEN1X95CIX


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UMLS:C1948073


subject: UNII:7J6GS9QIF0

object_name: rheumatoid arthritis


subject: DRUGBANK:DB16481

subject_name: Dociparstat sodium

object_name: acute myeloid leukemia by FAB classification


subject: DRUGBANK:DB16481

object_name: acute myeloid leukemia


subject: UMLS:C5203471

subject_name: Dexmedetomidine Liquid Injection

object_name: coronary artery disorder


subject: CHEBI:4466

subject_name: Dexmedetomidine


subject: CHEBI:39161

object_name: Labor Pain


subject: CHEBI:39161

object_name: morbid obesity


subject: CHEBI:4646

subject_name: Dipivefrin


subject: CHEBI:4646


subject: CHEBI:124939

subject_name: Rigosertib

object_name: Myelodysplasia


subject: CHEBI:124939

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:124939

object_name: childhood myelodysplastic syndrome


subject: CHEBI:124939

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:124939

object_name: Miller-Dieker lissencephaly syndrome


subject: CHEBI:124939

object_name: myoclonic dystonia 11


subject: CHEBI:124939

object_name: myelodysplastic syndrome with excess blasts


subject: UNII:WGD229O42W

subject_name: Tenecteplase

object_name: Ischemic stroke


subject: CHEBI:68579

subject_name: Rivaroxaban

object_name: aortic valve disorder


subject: CHEBI:68579

object_name: Thromboembolism


subject: MESH:C076628

subject_name: tyramine-deoxysorbitol

object_name: eustachian tube disorder


subject: MESH:C076628

object_name: Glue ear


subject: MESH:C076628

object_name: Acute otitis media


subject: MESH:C076628

object_name: ear barotrauma


subject: CHEBI:6339

subject_name: Etoricoxib

object_name: Post-Operative Pain


subject: UNII:3ZO554A4Q8

subject_name: Voxelotor

object_name: sickle cell disease


subject: CHEBI:83766

subject_name: Olaparib

object_name: Neck Carcinoma


subject: CHEBI:83766

object_name: head and neck neoplasm


subject: CHEBI:83766

object_name: head and neck cancer


subject: CHEBI:28955

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:28955

object_name: Plasma cell myeloma refractory


subject: CHEBI:28955

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:28955

object_name: DS Stage III Plasma Cell Myeloma


subject: UMLS:C3272757

subject_name: Live attenuated Influenza virus antigen only vaccine product

object_name: influenza


subject: UMLS:C3272757

object_name: Vaccine virus shedding


subject: CHEBI:66910

subject_name: Axitinib

object_name: Advanced renal cell carcinoma


subject: CHEBI:85994

subject_name: Lenvatinib


subject: UMLS:C5417881

subject_name: Volrustomig


subject: CHEBI:135117

subject_name: ftivazide

object_name: tuberculosis


subject: CHEBI:135117

object_name: HIV infection


subject: CHEBI:135117

object_name: pneumocystosis


subject: CHEBI:6030

subject_name: Isoniazid


subject: CHEBI:6030


subject: CHEBI:6030


subject: CHEBI:45924

subject_name: Trimethoprim


subject: CHEBI:45924


subject: CHEBI:45924


subject: CHEBI:9332

subject_name: Sulfamethoxazole


subject: CHEBI:9332


subject: CHEBI:9332


subject: CHEBI:133246

subject_name: Ligustrazine


subject: CHEBI:133246


subject: CHEBI:133246


subject: CHEBI:45394

subject_name: TMP


subject: CHEBI:45394


subject: CHEBI:45394


subject: CHEBI:46324

subject_name: trimethyl phosphate


subject: CHEBI:46324


subject: CHEBI:46324


subject: CHEBI:9533

subject_name: thiamine(1+) monophosphate


subject: CHEBI:9533


subject: CHEBI:9533


subject: CHEBI:17013

subject_name: dTMP


subject: CHEBI:17013


subject: CHEBI:17013


subject: CHEBI:63528


subject: CHEBI:63528


subject: CHEBI:63528


subject: UMLS:C0384479

subject_name: epithelial membrane protein-1


subject: UMLS:C0384479


subject: UMLS:C0384479


subject: PR:000007062

subject_name: epithelial membrane protein 1


subject: PR:000007062


subject: PR:000007062


subject: UniProtKB:P36590

subject_name: KTHY_SCHPO Thymidylate kinase (sprot)


subject: UniProtKB:P36590


subject: UniProtKB:P36590


subject: CHEMBL.COMPOUND:CHEMBL2109465

object_name: asthma


subject: GTOPDB:6749

subject_name: fibrinogen

object_name: pancreatic neoplasm


subject: GTOPDB:6749

object_name: malignant pancreatic neoplasm


subject: KEGG.COMPOUND:C00393

subject_name: Fibrinogen


subject: KEGG.COMPOUND:C00393


subject: UMLS:C3540039

subject_name: Fibrinogen containing hemostatics


subject: UMLS:C3540039


subject: UMLS:C2587184

subject_name: Parenogen


subject: UMLS:C2587184


subject: UMLS:C0016006


subject: UMLS:C0016006


subject: CHEBI:64321

subject_name: Fosaprepitant

object_name: Nausea, CTCAE_5


subject: CHEBI:64321

object_name: Nausea


subject: CHEBI:64321

object_name: Nausea, CTCAE_3


subject: CHEBI:64321

object_name: Vomiting, CTCAE


subject: CHEBI:64321

object_name: Vomiting


subject: CHEBI:64321

object_name: female reproductive system neoplasm


subject: UNII:420K487FSG

subject_name: Dupilumab

object_name: Steroid-dependent nephrotic syndrome


subject: UNII:420K487FSG

object_name: Nephrotic syndrome in children


subject: UMLS:C3658854


subject: UMLS:C3658854


subject: CHEBI:51041

subject_name: Acamprosate

object_name: schizophrenia


subject: CHEBI:51041

object_name: alcohol abuse


subject: CHEBI:51041

object_name: alcohol dependence


subject: UMLS:C4727547

subject_name: mRNA-based TriMix Melanoma Vaccine ECI-006

object_name: melanoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: adrenal carcinoma


subject: UNII:DPT0O3T46P

object_name: adrenal cortex carcinoma


subject: UNII:2158753C7E

subject_name: Relacorilant


subject: UNII:2158753C7E


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: Childhood Breast Carcinoma


subject: UNII:28X28X9OKV

object_name: breast carcinoma


subject: UNII:28X28X9OKV

object_name: breast cancer


subject: UNII:28X28X9OKV

object_name: luminal B breast carcinoma


subject: UNII:28X28X9OKV

object_name: triple-negative breast carcinoma


subject: UNII:28X28X9OKV

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: UMLS:C3641122


subject: CHEBI:91825

subject_name: Dapt

object_name: blood coagulation disease


subject: CHEBI:91825

object_name: hemorrhagic disease


subject: CHEBI:91825

object_name: Abnormal bleeding


subject: CHEBI:91825

object_name: coronary artery disorder


subject: CHEBI:91825

object_name: coronary atherosclerosis


subject: CHEBI:91825

object_name: kidney failure


subject: CHEBI:91825

object_name: hematologic disorder


subject: CHEBI:91825

object_name: thrombocytopenia


subject: CHEBI:91825

object_name: intracerebral hemorrhage


subject: CHEBI:91825

object_name: Ischemic stroke


subject: CHEBI:91825

object_name: anemia


subject: CHEBI:91825

object_name: Anemia, CTCAE


subject: UNII:949B9ZMO7M

subject_name: Diaminopropanol tetraacetic acid


subject: UNII:949B9ZMO7M


subject: UNII:949B9ZMO7M


subject: UNII:949B9ZMO7M


subject: UNII:949B9ZMO7M


subject: UNII:949B9ZMO7M


subject: UNII:949B9ZMO7M


subject: UNII:949B9ZMO7M


subject: UNII:949B9ZMO7M


subject: UNII:949B9ZMO7M


subject: UNII:949B9ZMO7M


subject: UNII:949B9ZMO7M


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: PUBCHEM.COMPOUND:6438565


subject: UNII:DPT0O3T46P

object_name: anaplastic meningioma


subject: UNII:DPT0O3T46P

object_name: Atypical Meningioma


subject: UNII:DPT0O3T46P

object_name: Adult Atypical Meningioma


subject: UNII:DPT0O3T46P

object_name: hemangiopericytoma


subject: UNII:DPT0O3T46P

object_name: myopericytoma


subject: UNII:DPT0O3T46P

object_name: solitary fibrous tumor


subject: CHEBI:9927

subject_name: Valsartan

object_name: essential hypertension


subject: CHEBI:2668

subject_name: Amlodipine


subject: CHEBI:45716

subject_name: Vorinostat

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:45716

object_name: Adult Mixed Cellularity Classical Hodgkin Lymphoma


subject: CHEBI:45716

object_name: Hodgkin's lymphoma, lymphocytic depletion


subject: CHEBI:45716

object_name: adult lymphocyte predominant Hodgkin lymphoma


subject: CHEBI:45716

object_name: Adult Nodular Sclerosis Classical Hodgkin Lymphoma


subject: CHEBI:45716

object_name: Adult Favorable Prognosis Hodgkin Lymphoma


subject: CHEBI:45716

object_name: Adult Unfavorable Prognosis Hodgkin Lymphoma


subject: CHEBI:45716

object_name: adult nodular lymphocyte predominant Hodgkin lymphoma


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: anus cancer


subject: UNII:PQX0D8J21J

object_name: anal carcinoma


subject: UMLS:C0879636

subject_name: IMC C225


subject: UMLS:C0879636


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil


subject: PUBCHEM.COMPOUND:14907381


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: UMLS:C5447484

subject_name: PD-1 Targeted IL-15 Mutein Fusion Protein PF-07209960

object_name: head and neck squamous cell carcinoma


subject: UMLS:C5447484

object_name: urothelial carcinoma


subject: UMLS:C5447484

object_name: transitional cell carcinoma


subject: UMLS:C5447484

object_name: colorectal carcinoma


subject: UMLS:C5447484

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C5447484

object_name: clear cell renal carcinoma


subject: UMLS:C5447484

object_name: renal cell adenocarcinoma


subject: UMLS:C5447484

object_name: renal cell carcinoma


subject: UMLS:C5447484

object_name: ovarian cancer


subject: UMLS:C5447484

object_name: ovarian carcinoma


subject: UMLS:C5447484

object_name: malignant epithelial tumor of ovary


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: Premature infant


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:8382

subject_name: Prednisone

object_name: immunoglobulin G4-related sclerosing disease


subject: CHEBI:8382

object_name: Immunoglobulin G4-Related Disease


subject: UMLS:C2974550

object_name: hepatitis C


subject: CHEBI:28747

subject_name: Picolinic acid

object_name: abdominal obesity-metabolic syndrome


subject: CHEBI:28747

object_name: metabolic syndrome X


subject: CHEBI:28747

object_name: metabolic disease


subject: CHEBI:28747

object_name: Prediabetes


subject: CHEBI:28747

object_name: type 2 diabetes mellitus


subject: CHEBI:28747

object_name: Insulin resistance


subject: CHEBI:28747

object_name: obesity due to melanocortin 4 receptor deficiency


subject: CHEBI:28747

object_name: obesity


subject: CHEBI:28747

object_name: Obesity, CTCAE


subject: CHEBI:50369

subject_name: Chromium picolinate


subject: CHEBI:50369


subject: CHEBI:50369


subject: CHEBI:50369


subject: CHEBI:50369


subject: CHEBI:50369


subject: CHEBI:50369


subject: CHEBI:50369


subject: CHEBI:50369


subject: CHEBI:85994

subject_name: Lenvatinib

object_name: liver carcinoma


subject: CHEBI:167664

object_name: Solid Neoplasm


subject: UMLS:C3641715


subject: CHEBI:90227

subject_name: Selumetinib


subject: MESH:C000608161

subject_name: glucopyranosyl lipid-A

object_name: HIV infection


subject: CHEBI:478164

subject_name: Cefepime

object_name: leukopenia


subject: CHEBI:478164

object_name: neutropenia


subject: CHEBI:478164

object_name: chronic neutrophilic leukemia


subject: CHEBI:478164

object_name: MALT lymphoma


subject: CHEBI:478164

object_name: Poor Prognosis Metastatic Gestational Trophoblastic Tumor


subject: CHEBI:478164

object_name: atypical chronic myeloid leukemia, BCR-ABL1 negative


subject: CHEBI:478164


subject: CHEBI:478164

object_name: Adult Diffuse Small Cleaved Cell Lymphoma


subject: CHEBI:478164

object_name: Adult Immunoblastic Lymphoma


subject: CHEBI:478164

object_name: malignant testicular germ cell tumor


subject: CHEBI:478164

object_name: Childhood Malignant Testicular Germ Cell Tumor


subject: CHEBI:478164

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: CHEBI:478164

object_name: primary cutaneous T-cell lymphoma


subject: CHEBI:478164

object_name: nodal marginal zone B-cell lymphoma


subject: CHEBI:478164

object_name: Adult Diffuse Large Cell Lymphoma


subject: CHEBI:478164

object_name: Adult Diffuse Mixed Cell Lymphoma


subject: CHEBI:478164

object_name: adult acute lymphoblastic leukemia


subject: CHEBI:478164

object_name: Mycosis fungoides/Sezary syndrome


subject: CHEBI:478164

object_name: juvenile myelomonocytic leukemia


subject: CHEBI:478164

object_name: chronic myelomonocytic leukemia


subject: CHEBI:478164

object_name: splenic marginal zone lymphoma


subject: CHEBI:478164

object_name: chronic eosinophilic leukemia


subject: CHEBI:478164

object_name: Disseminated neuroblastoma


subject: CHEBI:478164

object_name: Stage 4S neuroblastoma


subject: CHEBI:478164

object_name: ovarian germ cell tumor


subject: CHEBI:478164

object_name: pediatric ovarian germ cell tumor


subject: CHEBI:478164

object_name: adult acute myeloid leukemia


subject: CHEBI:478164

object_name: Adult Lymphoblastic Lymphoma


subject: CHEBI:478164

object_name: chronic myelogenous leukemia, BCR-ABL1 positive


subject: CHEBI:478164

object_name: B-cell chronic lymphocytic leukemia


subject: CHEBI:478164

object_name: ovarian carcinoma


subject: CHEBI:478164

object_name: malignant epithelial tumor of ovary


subject: CHEBI:478164

object_name: Lymphoma, Mixed-Cell, Follicular


subject: CHEBI:478164

object_name: Lymphoma, Small Cleaved-Cell, Follicular


subject: CHEBI:478164

object_name: Lymphoma, Large-Cell, Follicular


subject: CHEBI:478164

object_name: prolymphocytic leukemia


subject: CHEBI:478164

object_name: Myelodysplasia


subject: CHEBI:478164

object_name: mantle cell lymphoma


subject: CHEBI:478164

object_name: plasma cell myeloma


subject: CHEBI:478164

object_name: Plasma cell tumor, malignant


subject: CHEBI:478164

object_name: plasma cell neoplasm


subject: CHEBI:478164

object_name: Adult Burkitt Lymphoma


subject: CHEBI:478164

object_name: marginal zone lymphoma


subject: CHEBI:478164

object_name: Adult Hodgkin Lymphoma


subject: CHEBI:478164

object_name: Childhood Breast Carcinoma


subject: CHEBI:478164

object_name: breast carcinoma


subject: CHEBI:478164

object_name: breast cancer


subject: CHEBI:478164

object_name: myelofibrosis


subject: CHEBI:63577

subject_name: Lamivudine

object_name: Vertical Disease Transmission


subject: CHEBI:63577

object_name: Vertical human immunodeficiency virus transmission


subject: CHEBI:7496

subject_name: Nelfinavir


subject: CHEBI:7496


subject: CHEBI:7496

object_name: HIV infection


subject: CHEBI:63613

subject_name: Nevirapine


subject: CHEBI:63613


subject: UMLS:C0919075

subject_name: INJECTION, ZIDOVUDINE, 10 MG ADMINISTERED


subject: UMLS:C0919075


subject: CHEBI:10110

subject_name: Zidovudine


subject: CHEBI:10110


subject: UNII:L1F3R18W77

subject_name: Asciminib

object_name: Chronic myeloid leukemia in remission


subject: UNII:L1F3R18W77

object_name: Chronic myeloid leukemia, BCR/ABL-positive


subject: CHEBI:167309

subject_name: Methadone

object_name: neoplasm


subject: CHEBI:58097


subject: CHEBI:17303

subject_name: Morphine


subject: UNII:MA10QYF1Z0

subject_name: Ferric maltol

object_name: inflammatory bowel disease


subject: UNII:MA10QYF1Z0

object_name: Crohn disease


subject: CHEBI:63632

subject_name: Topotecan

object_name: peritoneum cancer


subject: CHEBI:63632

object_name: fallopian tube carcinoma


subject: CHEBI:63632

object_name: fallopian tube cancer


subject: CHEBI:71028

subject_name: Carglumic acid

object_name: methylmalonic acidemia


subject: CHEBI:71028

object_name: propionic acidemia


subject: UMLS:C0067889

subject_name: carglumic acid


subject: UMLS:C0067889


subject: MESH:C577143

object_name: hemophilia A


subject: MESH:C577143

object_name: hemophilia


subject: CHEBI:83766

subject_name: Olaparib

object_name: Metastatic Bile Duct Carcinoma


subject: CHEBI:83766

object_name: Fanconi Anemia Complementation Group Gene Mutation


subject: CHEBI:83766

object_name: PTEN Gene Deletion


subject: CHEBI:83766

object_name: bile duct adenocarcinoma


subject: UNII:4FR53SIF3A

subject_name: Blinatumomab

object_name: precursor B-cell acute lymphoblastic leukemia


subject: CHEBI:139072

object_name: migraine


subject: CHEBI:139072

object_name: migraine with or without aura, susceptibility to, 1


subject: CHEBI:8614

subject_name: Psilocybin


subject: CHEBI:8614


subject: CHEBI:135930

subject_name: Lercanidipine

object_name: obesity due to congenital leptin deficiency


subject: CHEBI:135930

object_name: obesity due to leptin receptor gene deficiency


subject: CHEBI:135930

object_name: morbid obesity


subject: UMLS:C4048794

object_name: glioblastoma


subject: UMLS:C4048794

object_name: Brain Stem Glioblastoma


subject: UMLS:C4048794

object_name: glioma susceptibility 1


subject: CHEBI:10023

subject_name: Voriconazole

object_name: Infection


subject: CHEBI:10023

object_name: infectious disease


subject: CHEBI:10023

object_name: Adverse Event Associated with Infection


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: pulmonary hypertension


subject: PUBCHEM.COMPOUND:9919001

subject_name: FORMOTEROL FUMARATE

object_name: Chronic obstructive pulmonary disease of horses


subject: PUBCHEM.COMPOUND:9919001

object_name: COPD, severe early onset


subject: CHEBI:408174

subject_name: Arformoterol


subject: CHEBI:408174


subject: CHEBI:51032

subject_name: Epinastine

object_name: atopic conjunctivitis


subject: MESH:C000712049

subject_name: Monatide (IMS 3015)

object_name: ovarian carcinoma


subject: MESH:C000712049

object_name: malignant epithelial tumor of ovary


subject: MESH:C000712049

object_name: primary peritoneal carcinoma


subject: MESH:C000712049

object_name: Primary Peritoneal Cancer


subject: MESH:C000712049

object_name: fallopian tube carcinoma


subject: MESH:C000712049

object_name: fallopian tube cancer


subject: DRUGBANK:DB17293

subject_name: Hiltonol


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: DRUGBANK:DB17293


subject: UNII:7KYP9TKT70

subject_name: poly ICLC


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: UNII:7KYP9TKT70


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Blasts Under 5 Percent of Bone Marrow Nucleated Cells


subject: CHEBI:4026

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: CHEBI:4026

object_name: acute myeloid leukemia, t(6;9)(p23;q34.1)


subject: CHEBI:4026

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:4026

object_name: acute myeloid leukemia with multilineage dysplasia


subject: CHEBI:4026

object_name: acute myeloid leukemia, inv(3)(q21.3;q26.2)


subject: CHEBI:4026

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: CHEBI:4026

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:4026

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:4026

object_name: Childhood Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:4026

object_name: B-cell acute lymphoblastic leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)


subject: CHEBI:4026

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:4026

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:4026

object_name: acute undifferentiated leukemia


subject: CHEBI:4026

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:4026

object_name: acute biphenotypic leukemia


subject: CHEBI:4026

object_name: Infant Acute Biphenotypic Leukemia


subject: CHEBI:4026

object_name: Acute Erythroid Leukemia in Remission


subject: CHEBI:4026

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:4026

object_name: Follicular lymphoma recurrent


subject: CHEBI:4026

object_name: Adult Acute Leukemia in Remission


subject: CHEBI:4026

object_name: Childhood Acute Leukemia in Remission


subject: CHEBI:4026

object_name: Acute leukemia in remission


subject: CHEBI:4026

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:4026

object_name: Ph-positive acute lymphoblastic leukemia


subject: CHEBI:4027

subject_name: Cyclophosphamide

object_name: Blasts Under 5 Percent of Bone Marrow Nucleated Cells


subject: CHEBI:4027

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: CHEBI:4027

object_name: acute myeloid leukemia, t(6;9)(p23;q34.1)


subject: CHEBI:4027

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:4027

object_name: acute myeloid leukemia with multilineage dysplasia


subject: CHEBI:4027

object_name: acute myeloid leukemia, inv(3)(q21.3;q26.2)


subject: CHEBI:4027

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: CHEBI:4027

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:4027

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:4027

object_name: Childhood Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:4027

object_name: B-cell acute lymphoblastic leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)


subject: CHEBI:4027

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:4027

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:4027

object_name: acute undifferentiated leukemia


subject: CHEBI:4027

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:4027

object_name: acute biphenotypic leukemia


subject: CHEBI:4027

object_name: Infant Acute Biphenotypic Leukemia


subject: CHEBI:4027

object_name: Acute Erythroid Leukemia in Remission


subject: CHEBI:4027

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:4027

object_name: Follicular lymphoma recurrent


subject: CHEBI:4027

object_name: Adult Acute Leukemia in Remission


subject: CHEBI:4027

object_name: Childhood Acute Leukemia in Remission


subject: CHEBI:4027

object_name: Acute leukemia in remission


subject: CHEBI:4027

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:4027

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:4027

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:4027

object_name: Ph-positive acute lymphoblastic leukemia


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim

object_name: Blasts Under 5 Percent of Bone Marrow Nucleated Cells


subject: UNII:PVI5M0M1GW

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: UNII:PVI5M0M1GW

object_name: acute myeloid leukemia, t(6;9)(p23;q34.1)


subject: UNII:PVI5M0M1GW

object_name: DS Stage II Plasma Cell Myeloma


subject: UNII:PVI5M0M1GW

object_name: acute myeloid leukemia with multilineage dysplasia


subject: UNII:PVI5M0M1GW

object_name: acute myeloid leukemia, inv(3)(q21.3;q26.2)


subject: UNII:PVI5M0M1GW

object_name: Plasma cell myeloma recurrent


subject: UNII:PVI5M0M1GW

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: UNII:PVI5M0M1GW

object_name: DS Stage III Plasma Cell Myeloma


subject: UNII:PVI5M0M1GW

object_name: Childhood Acute Lymphoblastic Leukemia in Complete Remission


subject: UNII:PVI5M0M1GW

object_name: B-cell acute lymphoblastic leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)


subject: UNII:PVI5M0M1GW

object_name: Adult Acute Lymphoblastic Leukemia in Complete Remission


subject: UNII:PVI5M0M1GW

object_name: Acute myeloid leukemia in remission


subject: UNII:PVI5M0M1GW

object_name: Plasma cell myeloma refractory


subject: UNII:PVI5M0M1GW

object_name: Mantle cell lymphoma recurrent


subject: UNII:PVI5M0M1GW

object_name: Infant Acute Undifferentiated Leukemia


subject: UNII:PVI5M0M1GW

object_name: acute undifferentiated leukemia


subject: UNII:PVI5M0M1GW

object_name: Acute lymphoid leukemia in remission


subject: UNII:PVI5M0M1GW

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UNII:PVI5M0M1GW

object_name: acute biphenotypic leukemia


subject: UNII:PVI5M0M1GW

object_name: Infant Acute Biphenotypic Leukemia


subject: UNII:PVI5M0M1GW

object_name: Acute Erythroid Leukemia in Remission


subject: UNII:PVI5M0M1GW

object_name: Myelodysplasia


subject: UNII:PVI5M0M1GW

object_name: Adult Myelodysplastic Syndrome


subject: UNII:PVI5M0M1GW

object_name: childhood myelodysplastic syndrome


subject: UNII:PVI5M0M1GW

object_name: Myelodysplastic Syndrome, CTCAE


subject: UNII:PVI5M0M1GW

object_name: Marginal zone lymphoma recurrent


subject: UNII:PVI5M0M1GW

object_name: Follicular lymphoma recurrent


subject: UNII:PVI5M0M1GW

object_name: Adult Acute Leukemia in Remission


subject: UNII:PVI5M0M1GW

object_name: Childhood Acute Leukemia in Remission


subject: UNII:PVI5M0M1GW

object_name: Acute leukemia in remission


subject: UNII:PVI5M0M1GW

object_name: T-cell childhood lymphoblastic lymphoma


subject: UNII:PVI5M0M1GW

object_name: Adult T Lymphoblastic Lymphoma


subject: UNII:PVI5M0M1GW

object_name: T-lymphoblastic lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Hodgkin Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Recurrent Adult Hodgkin Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Burkitt lymphoma


subject: UNII:PVI5M0M1GW

object_name: Childhood Burkitt Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Adult Burkitt Lymphoma


subject: UNII:PVI5M0M1GW

object_name: Ph-positive acute lymphoblastic leukemia


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor

object_name: Blasts Under 5 Percent of Bone Marrow Nucleated Cells


subject: PR:000005932

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: PR:000005932

object_name: acute myeloid leukemia, t(6;9)(p23;q34.1)


subject: PR:000005932

object_name: DS Stage II Plasma Cell Myeloma


subject: PR:000005932

object_name: acute myeloid leukemia with multilineage dysplasia


subject: PR:000005932

object_name: acute myeloid leukemia, inv(3)(q21.3;q26.2)


subject: PR:000005932

object_name: Plasma cell myeloma recurrent


subject: PR:000005932

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: PR:000005932

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: PR:000005932

object_name: DS Stage III Plasma Cell Myeloma


subject: PR:000005932

object_name: Childhood Acute Lymphoblastic Leukemia in Complete Remission


subject: PR:000005932

object_name: B-cell acute lymphoblastic leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)


subject: PR:000005932

object_name: Adult Acute Lymphoblastic Leukemia in Complete Remission


subject: PR:000005932

object_name: Acute myeloid leukemia in remission


subject: PR:000005932

object_name: Plasma cell myeloma refractory


subject: PR:000005932

object_name: Mantle cell lymphoma recurrent


subject: PR:000005932

object_name: Infant Acute Undifferentiated Leukemia


subject: PR:000005932

object_name: acute undifferentiated leukemia


subject: PR:000005932

object_name: Acute lymphoid leukemia in remission


subject: PR:000005932

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: PR:000005932

object_name: acute biphenotypic leukemia


subject: PR:000005932

object_name: Infant Acute Biphenotypic Leukemia


subject: PR:000005932

object_name: Acute Erythroid Leukemia in Remission


subject: PR:000005932

object_name: Myelodysplasia


subject: PR:000005932

object_name: Adult Myelodysplastic Syndrome


subject: PR:000005932

object_name: childhood myelodysplastic syndrome


subject: PR:000005932

object_name: Myelodysplastic Syndrome, CTCAE


subject: PR:000005932

object_name: Marginal zone lymphoma recurrent


subject: PR:000005932

object_name: Follicular lymphoma recurrent


subject: PR:000005932

object_name: Adult Acute Leukemia in Remission


subject: PR:000005932

object_name: Childhood Acute Leukemia in Remission


subject: PR:000005932

object_name: Acute leukemia in remission


subject: PR:000005932

object_name: T-cell childhood lymphoblastic lymphoma


subject: PR:000005932

object_name: Adult T Lymphoblastic Lymphoma


subject: PR:000005932

object_name: T-lymphoblastic lymphoma


subject: PR:000005932

object_name: Recurrent Hodgkin Lymphoma


subject: PR:000005932

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: PR:000005932

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PR:000005932

object_name: Burkitt lymphoma


subject: PR:000005932

object_name: Childhood Burkitt Lymphoma


subject: PR:000005932

object_name: Adult Burkitt Lymphoma


subject: PR:000005932

object_name: Ph-positive acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:3368

subject_name: Fludara

object_name: Blasts Under 5 Percent of Bone Marrow Nucleated Cells


subject: PUBCHEM.COMPOUND:3368

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: PUBCHEM.COMPOUND:3368

object_name: acute myeloid leukemia, t(6;9)(p23;q34.1)


subject: PUBCHEM.COMPOUND:3368

object_name: DS Stage II Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:3368

object_name: acute myeloid leukemia with multilineage dysplasia


subject: PUBCHEM.COMPOUND:3368

object_name: acute myeloid leukemia, inv(3)(q21.3;q26.2)


subject: PUBCHEM.COMPOUND:3368

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:3368

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: DS Stage III Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:3368

object_name: Childhood Acute Lymphoblastic Leukemia in Complete Remission


subject: PUBCHEM.COMPOUND:3368

object_name: B-cell acute lymphoblastic leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)


subject: PUBCHEM.COMPOUND:3368

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:3368

object_name: Mantle cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:3368

object_name: Infant Acute Undifferentiated Leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: acute undifferentiated leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: Acute lymphoid leukemia in remission


subject: PUBCHEM.COMPOUND:3368

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:3368

object_name: acute biphenotypic leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: Infant Acute Biphenotypic Leukemia


subject: PUBCHEM.COMPOUND:3368

object_name: Acute Erythroid Leukemia in Remission


subject: PUBCHEM.COMPOUND:3368

object_name: Marginal zone lymphoma recurrent


subject: PUBCHEM.COMPOUND:3368

object_name: Follicular lymphoma recurrent


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Acute Leukemia in Remission


subject: PUBCHEM.COMPOUND:3368

object_name: Childhood Acute Leukemia in Remission


subject: PUBCHEM.COMPOUND:3368

object_name: Acute leukemia in remission


subject: PUBCHEM.COMPOUND:3368

object_name: T-cell childhood lymphoblastic lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Adult T Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: T-lymphoblastic lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Recurrent Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Burkitt lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Childhood Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Adult Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:3368

object_name: Ph-positive acute lymphoblastic leukemia


subject: CHEBI:63599

subject_name: Fludarabine

object_name: Blasts Under 5 Percent of Bone Marrow Nucleated Cells


subject: CHEBI:63599

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: CHEBI:63599

object_name: acute myeloid leukemia, t(6;9)(p23;q34.1)


subject: CHEBI:63599

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:63599

object_name: acute myeloid leukemia with multilineage dysplasia


subject: CHEBI:63599

object_name: acute myeloid leukemia, inv(3)(q21.3;q26.2)


subject: CHEBI:63599

object_name: Plasma cell myeloma recurrent


subject: CHEBI:63599

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: CHEBI:63599

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:63599

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:63599

object_name: Childhood Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:63599

object_name: B-cell acute lymphoblastic leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)


subject: CHEBI:63599

object_name: Plasma cell myeloma refractory


subject: CHEBI:63599

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:63599

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:63599

object_name: acute undifferentiated leukemia


subject: CHEBI:63599

object_name: Acute lymphoid leukemia in remission


subject: CHEBI:63599

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:63599

object_name: Infant Acute Biphenotypic Leukemia


subject: CHEBI:63599

object_name: Acute Erythroid Leukemia in Remission


subject: CHEBI:63599

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:63599

object_name: Follicular lymphoma recurrent


subject: CHEBI:63599

object_name: Adult Acute Leukemia in Remission


subject: CHEBI:63599

object_name: Childhood Acute Leukemia in Remission


subject: CHEBI:63599

object_name: Acute leukemia in remission


subject: CHEBI:63599

object_name: T-cell childhood lymphoblastic lymphoma


subject: CHEBI:63599

object_name: Adult T Lymphoblastic Lymphoma


subject: CHEBI:63599

object_name: T-lymphoblastic lymphoma


subject: CHEBI:63599

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:63599

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:63599

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:63599

object_name: Ph-positive acute lymphoblastic leukemia


subject: CHEBI:168396

subject_name: Mycophenolic acid

object_name: Blasts Under 5 Percent of Bone Marrow Nucleated Cells


subject: CHEBI:168396

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: CHEBI:168396

object_name: acute myeloid leukemia, t(6;9)(p23;q34.1)


subject: CHEBI:168396

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:168396

object_name: acute myeloid leukemia with multilineage dysplasia


subject: CHEBI:168396

object_name: acute myeloid leukemia, inv(3)(q21.3;q26.2)


subject: CHEBI:168396

object_name: Plasma cell myeloma recurrent


subject: CHEBI:168396

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: CHEBI:168396

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:168396

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:168396

object_name: Childhood Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:168396

object_name: B-cell acute lymphoblastic leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)


subject: CHEBI:168396

object_name: Plasma cell myeloma refractory


subject: CHEBI:168396

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:168396

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:168396

object_name: acute undifferentiated leukemia


subject: CHEBI:168396

object_name: Acute lymphoid leukemia in remission


subject: CHEBI:168396

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:168396

object_name: acute biphenotypic leukemia


subject: CHEBI:168396

object_name: Infant Acute Biphenotypic Leukemia


subject: CHEBI:168396

object_name: Acute Erythroid Leukemia in Remission


subject: CHEBI:168396

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:168396

object_name: Follicular lymphoma recurrent


subject: CHEBI:168396

object_name: Adult Acute Leukemia in Remission


subject: CHEBI:168396

object_name: Childhood Acute Leukemia in Remission


subject: CHEBI:168396

object_name: Acute leukemia in remission


subject: CHEBI:168396

object_name: T-cell childhood lymphoblastic lymphoma


subject: CHEBI:168396

object_name: Adult T Lymphoblastic Lymphoma


subject: CHEBI:168396

object_name: T-lymphoblastic lymphoma


subject: CHEBI:168396

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:168396

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:168396

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:168396

object_name: Burkitt lymphoma


subject: CHEBI:168396

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:168396

object_name: Adult Burkitt Lymphoma


subject: CHEBI:168396

object_name: Ph-positive acute lymphoblastic leukemia


subject: CHEBI:8764

subject_name: Mycophenolate mofetil

object_name: Blasts Under 5 Percent of Bone Marrow Nucleated Cells


subject: CHEBI:8764

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: CHEBI:8764

object_name: acute myeloid leukemia, t(6;9)(p23;q34.1)


subject: CHEBI:8764

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:8764

object_name: acute myeloid leukemia with multilineage dysplasia


subject: CHEBI:8764

object_name: acute myeloid leukemia, inv(3)(q21.3;q26.2)


subject: CHEBI:8764

object_name: Plasma cell myeloma recurrent


subject: CHEBI:8764

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: CHEBI:8764

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:8764

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:8764

object_name: Childhood Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:8764

object_name: B-cell acute lymphoblastic leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)


subject: CHEBI:8764

object_name: Plasma cell myeloma refractory


subject: CHEBI:8764

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:8764

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:8764

object_name: acute undifferentiated leukemia


subject: CHEBI:8764

object_name: Acute lymphoid leukemia in remission


subject: CHEBI:8764

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:8764

object_name: acute biphenotypic leukemia


subject: CHEBI:8764

object_name: Infant Acute Biphenotypic Leukemia


subject: CHEBI:8764

object_name: Acute Erythroid Leukemia in Remission


subject: CHEBI:8764

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:8764

object_name: Follicular lymphoma recurrent


subject: CHEBI:8764

object_name: Adult Acute Leukemia in Remission


subject: CHEBI:8764

object_name: Childhood Acute Leukemia in Remission


subject: CHEBI:8764

object_name: Acute leukemia in remission


subject: CHEBI:8764

object_name: T-cell childhood lymphoblastic lymphoma


subject: CHEBI:8764

object_name: Adult T Lymphoblastic Lymphoma


subject: CHEBI:8764

object_name: T-lymphoblastic lymphoma


subject: CHEBI:8764

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:8764

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:8764

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:8764

object_name: Burkitt lymphoma


subject: CHEBI:8764

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:8764

object_name: Adult Burkitt Lymphoma


subject: CHEBI:8764

object_name: Ph-positive acute lymphoblastic leukemia


subject: CHEBI:61057

subject_name: TACROLIMUS

object_name: Blasts Under 5 Percent of Bone Marrow Nucleated Cells


subject: CHEBI:61057

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: CHEBI:61057

object_name: acute myeloid leukemia, t(6;9)(p23;q34.1)


subject: CHEBI:61057

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:61057

object_name: acute myeloid leukemia with multilineage dysplasia


subject: CHEBI:61057

object_name: acute myeloid leukemia, inv(3)(q21.3;q26.2)


subject: CHEBI:61057

object_name: Plasma cell myeloma recurrent


subject: CHEBI:61057

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: CHEBI:61057

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:61057

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:61057

object_name: Childhood Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:61057

object_name: B-cell acute lymphoblastic leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)


subject: CHEBI:61057

object_name: Adult Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:61057

object_name: Acute myeloid leukemia in remission


subject: CHEBI:61057

object_name: Plasma cell myeloma refractory


subject: CHEBI:61057

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:61057

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:61057

object_name: acute undifferentiated leukemia


subject: CHEBI:61057

object_name: Acute lymphoid leukemia in remission


subject: CHEBI:61057

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:61057

object_name: acute biphenotypic leukemia


subject: CHEBI:61057

object_name: Infant Acute Biphenotypic Leukemia


subject: CHEBI:61057

object_name: Acute Erythroid Leukemia in Remission


subject: CHEBI:61057

object_name: Myelodysplasia


subject: CHEBI:61057

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:61057

object_name: childhood myelodysplastic syndrome


subject: CHEBI:61057

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:61057

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:61057

object_name: Follicular lymphoma recurrent


subject: CHEBI:61057

object_name: Adult Acute Leukemia in Remission


subject: CHEBI:61057

object_name: Childhood Acute Leukemia in Remission


subject: CHEBI:61057

object_name: Acute leukemia in remission


subject: CHEBI:61057

object_name: T-cell childhood lymphoblastic lymphoma


subject: CHEBI:61057

object_name: Adult T Lymphoblastic Lymphoma


subject: CHEBI:61057

object_name: T-lymphoblastic lymphoma


subject: CHEBI:61057

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:61057

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:61057

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:61057

object_name: Burkitt lymphoma


subject: CHEBI:61057

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:61057

object_name: Adult Burkitt Lymphoma


subject: CHEBI:61057

object_name: Ph-positive acute lymphoblastic leukemia


subject: PUBCHEM.COMPOUND:5372

object_name: Blasts Under 5 Percent of Bone Marrow Nucleated Cells


subject: PUBCHEM.COMPOUND:5372

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: PUBCHEM.COMPOUND:5372

object_name: acute myeloid leukemia, t(6;9)(p23;q34.1)


subject: PUBCHEM.COMPOUND:5372

object_name: DS Stage II Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:5372

object_name: acute myeloid leukemia with multilineage dysplasia


subject: PUBCHEM.COMPOUND:5372

object_name: acute myeloid leukemia, inv(3)(q21.3;q26.2)


subject: PUBCHEM.COMPOUND:5372

object_name: Plasma cell myeloma recurrent


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: DS Stage III Plasma Cell Myeloma


subject: PUBCHEM.COMPOUND:5372

object_name: Childhood Acute Lymphoblastic Leukemia in Complete Remission


subject: PUBCHEM.COMPOUND:5372

object_name: B-cell acute lymphoblastic leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)


subject: PUBCHEM.COMPOUND:5372

object_name: Adult Acute Lymphoblastic Leukemia in Complete Remission


subject: PUBCHEM.COMPOUND:5372

object_name: Acute myeloid leukemia in remission


subject: PUBCHEM.COMPOUND:5372

object_name: Plasma cell myeloma refractory


subject: PUBCHEM.COMPOUND:5372

object_name: Mantle cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:5372

object_name: Infant Acute Undifferentiated Leukemia


subject: PUBCHEM.COMPOUND:5372

object_name: acute undifferentiated leukemia


subject: PUBCHEM.COMPOUND:5372

object_name: Acute lymphoid leukemia in remission


subject: PUBCHEM.COMPOUND:5372

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:5372

object_name: acute biphenotypic leukemia


subject: PUBCHEM.COMPOUND:5372

object_name: Infant Acute Biphenotypic Leukemia


subject: PUBCHEM.COMPOUND:5372

object_name: Acute Erythroid Leukemia in Remission


subject: PUBCHEM.COMPOUND:5372

object_name: Myelodysplasia


subject: PUBCHEM.COMPOUND:5372

object_name: Adult Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:5372

object_name: childhood myelodysplastic syndrome


subject: PUBCHEM.COMPOUND:5372

object_name: Myelodysplastic Syndrome, CTCAE


subject: PUBCHEM.COMPOUND:5372

object_name: Marginal zone lymphoma recurrent


subject: PUBCHEM.COMPOUND:5372

object_name: Follicular lymphoma recurrent


subject: PUBCHEM.COMPOUND:5372

object_name: Adult Acute Leukemia in Remission


subject: PUBCHEM.COMPOUND:5372

object_name: Childhood Acute Leukemia in Remission


subject: PUBCHEM.COMPOUND:5372

object_name: Acute leukemia in remission


subject: PUBCHEM.COMPOUND:5372

object_name: T-cell childhood lymphoblastic lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Adult T Lymphoblastic Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: T-lymphoblastic lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Recurrent Adult Hodgkin Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Burkitt lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Childhood Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Adult Burkitt Lymphoma


subject: PUBCHEM.COMPOUND:5372

object_name: Ph-positive acute lymphoblastic leukemia


subject: CHEBI:61049

subject_name: Tacrolimus

object_name: Blasts Under 5 Percent of Bone Marrow Nucleated Cells


subject: CHEBI:61049

object_name: acute myeloid leukemia, FLT3 internal tandem duplication


subject: CHEBI:61049

object_name: acute myeloid leukemia, t(6;9)(p23;q34.1)


subject: CHEBI:61049

object_name: DS Stage II Plasma Cell Myeloma


subject: CHEBI:61049

object_name: acute myeloid leukemia with multilineage dysplasia


subject: CHEBI:61049

object_name: acute myeloid leukemia, inv(3)(q21.3;q26.2)


subject: CHEBI:61049

object_name: Plasma cell myeloma recurrent


subject: CHEBI:61049

object_name: Recurrent Anaplastic Large Cell Lymphoma


subject: CHEBI:61049

object_name: Recurrent Childhood Anaplastic Large Cell Lymphoma


subject: CHEBI:61049

object_name: DS Stage III Plasma Cell Myeloma


subject: CHEBI:61049

object_name: Childhood Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:61049

object_name: B-cell acute lymphoblastic leukemia with t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1)


subject: CHEBI:61049

object_name: Adult Acute Lymphoblastic Leukemia in Complete Remission


subject: CHEBI:61049

object_name: Acute myeloid leukemia in remission


subject: CHEBI:61049

object_name: Plasma cell myeloma refractory


subject: CHEBI:61049

object_name: Mantle cell lymphoma recurrent


subject: CHEBI:61049

object_name: Infant Acute Undifferentiated Leukemia


subject: CHEBI:61049

object_name: acute undifferentiated leukemia


subject: CHEBI:61049

object_name: Acute lymphoid leukemia in remission


subject: CHEBI:61049

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: CHEBI:61049

object_name: acute biphenotypic leukemia


subject: CHEBI:61049

object_name: Infant Acute Biphenotypic Leukemia


subject: CHEBI:61049

object_name: Acute Erythroid Leukemia in Remission


subject: CHEBI:61049

object_name: Myelodysplasia


subject: CHEBI:61049

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:61049

object_name: childhood myelodysplastic syndrome


subject: CHEBI:61049

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:61049

object_name: Marginal zone lymphoma recurrent


subject: CHEBI:61049

object_name: Follicular lymphoma recurrent


subject: CHEBI:61049

object_name: Adult Acute Leukemia in Remission


subject: CHEBI:61049

object_name: Childhood Acute Leukemia in Remission


subject: CHEBI:61049

object_name: Acute leukemia in remission


subject: CHEBI:61049

object_name: T-cell childhood lymphoblastic lymphoma


subject: CHEBI:61049

object_name: Adult T Lymphoblastic Lymphoma


subject: CHEBI:61049

object_name: T-lymphoblastic lymphoma


subject: CHEBI:61049

object_name: Recurrent Hodgkin Lymphoma


subject: CHEBI:61049

object_name: Recurrent Childhood Hodgkin Lymphoma


subject: CHEBI:61049

object_name: Recurrent Adult Hodgkin Lymphoma


subject: CHEBI:61049

object_name: Burkitt lymphoma


subject: CHEBI:61049

object_name: Childhood Burkitt Lymphoma


subject: CHEBI:61049

object_name: Adult Burkitt Lymphoma


subject: CHEBI:61049

object_name: Ph-positive acute lymphoblastic leukemia


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: Postoperative Pain, Acute


subject: CHEBI:46195

subject_name: Acetaminophen

object_name: patent ductus arteriosus


subject: UMLS:C2917659

subject_name: Acetaminophen [EPC]


subject: PUBCHEM.COMPOUND:3367

object_name: leukemia


subject: PUBCHEM.COMPOUND:3367

object_name: childhood leukemia


subject: CHEBI:63599


subject: CHEBI:63599


subject: CHEBI:45783

subject_name: Imatinib

object_name: graft versus host disease


subject: CHEBI:45783

object_name: systemic sclerosis


subject: UNII:4F4X42SYQ6

subject_name: Rituximab


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:3423

subject_name: Carmustine

object_name: mantle cell lymphoma


subject: CHEBI:3423

object_name: Refractory Indolent Adult Non-Hodgkin Lymphoma


subject: CHEBI:3423

object_name: Follicular lymphoma recurrent


subject: CHEBI:3423

object_name: Recurrent Indolent Adult Non-Hodgkin Lymphoma


subject: CHEBI:3423

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: CHEBI:3423

object_name: Follicular lymphoma refractory


subject: CHEBI:3423

object_name: Diffuse large B-cell lymphoma recurrent


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: PUBCHEM.COMPOUND:596


subject: CHEBI:28680

subject_name: Cytarabine


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:28680


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: CHEBI:4911


subject: UNII:PVI5M0M1GW

subject_name: Filgrastim


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: UNII:PVI5M0M1GW


subject: PR:000005932

subject_name: granulocyte colony-stimulating factor


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: PR:000005932


subject: CHEBI:63791

subject_name: Lenalidomide


subject: CHEBI:63791


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UNII:4F4X42SYQ6


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0295415


subject: UMLS:C0450164

subject_name: dental products fluoride toothpaste

object_name: Tooth Demineralization


subject: UMLS:C0450164

object_name: dental caries


subject: CHEBI:6520

subject_name: Lomustine

object_name: Recurrent Malignant Glioma


subject: CHEBI:143658


subject: CHEBI:28445

subject_name: vincristine


subject: CHEBI:71417

subject_name: Procarbazine


subject: CHEBI:63605

subject_name: Ixabepilone

object_name: HER2 positive breast carcinoma


subject: CHEBI:63605

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:63605

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:63605

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:63605

object_name: Breast cancer recurrent


subject: CHEBI:231601

subject_name: trastuzumab


subject: CHEBI:231601

object_name: Carcinoma breast stage IV


subject: CHEBI:231601


subject: CHEBI:231601


subject: CHEBI:231601


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: UMLS:C0338204


subject: CHEBI:135779

subject_name: Amrubicin

object_name: small cell lung carcinoma


subject: CHEBI:47097

subject_name: Lonafarnib

object_name: progeria


subject: CHEBI:31355

subject_name: Carboplatin

object_name: metastatic melanoma


subject: PUBCHEM.COMPOUND:70789204

subject_name: Everolimus


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:64816

object_name: cancer


subject: CHEBI:64816

object_name: neoplasm


subject: CHEBI:91872


subject: CHEBI:91872


subject: CHEBI:28748

subject_name: Doxorubicin


subject: CHEBI:28748


subject: PUBCHEM.COMPOUND:72995075

subject_name: Ulimorelin

object_name: digestive system disorder


subject: CHEBI:8805

subject_name: Repaglinide

object_name: rheumatoid arthritis


subject: CHEBI:10033

subject_name: Warfarin


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: traumatic encephalopathy


subject: UNII:MRL3739G66

subject_name: Dotatate

object_name: neuroendocrine neoplasm


subject: UNII:2QN49PWH71

subject_name: benzylmandelate

object_name: Urinary Urgency


subject: PUBCHEM.COMPOUND:5284632

subject_name: Trospium


subject: CHEBI:84500

subject_name: varenicline

object_name: alcohol abuse


subject: CHEBI:84500

object_name: alcohol dependence


subject: CHEBI:84507

subject_name: Chantix


subject: CHEBI:84507


subject: PUBCHEM.COMPOUND:46783232

subject_name: Champix


subject: PUBCHEM.COMPOUND:46783232


subject: UMLS:C1956439


subject: UMLS:C1956439


subject: UMLS:C1581084

subject_name: sodium bicarbonate 8.4 %

object_name: brain edema


subject: CHEBI:231614

subject_name: Nivolumab

object_name: urinary bladder carcinoma


subject: CHEBI:231614

object_name: urinary bladder cancer


subject: CHEBI:231614

object_name: childhood bladder carcinoma


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: GTOPDB:9310

subject_name: lirilumab

object_name: bladder tumor


subject: GTOPDB:9310


subject: GTOPDB:9310


subject: GTOPDB:9310


subject: UNII:S9XDI9W918

subject_name: LIRILUMAB


subject: UNII:S9XDI9W918


subject: UNII:S9XDI9W918


subject: UNII:S9XDI9W918


subject: UMLS:C3641620


subject: UMLS:C3641620


subject: UMLS:C3641620


subject: UMLS:C3641620


subject: CHEBI:125427


subject: CHEBI:125427

object_name: Crohn disease


subject: UMLS:C3714610

subject_name: Calcitriol Drug Class


subject: UMLS:C3714610


subject: CHEBI:17823

subject_name: Calcitriol


subject: CHEBI:17823


subject: PUBCHEM.COMPOUND:74328238

subject_name: Sotagliflozin

object_name: type 1 diabetes mellitus 1


subject: PUBCHEM.COMPOUND:74328238

object_name: type 1 diabetes mellitus


subject: PUBCHEM.COMPOUND:22976653

subject_name: TTPA

object_name: Acute Ischemic Stroke


subject: UNII:1RXS4UE564

subject_name: Alteplase


subject: PR:000012825

subject_name: tissue-type plasminogen activator


subject: PUBCHEM.COMPOUND:2767

subject_name: Cisplatin

object_name: Small cell lung cancer limited stage


subject: CHEBI:4911

subject_name: Etoposide


subject: CHEBI:78887

subject_name: Tirapazamine


subject: UNII:NY0COC51FI

subject_name: Tradipitant


subject: UNII:NY0COC51FI


subject: CHEBI:132922

object_name: Episodic migraine


subject: CHEBI:43415

subject_name: Dexibuprofen


subject: CHEBI:5855

subject_name: Ibuprofen


subject: CHEBI:63450

subject_name: Masitinib

object_name: multiple sclerosis


subject: PUBCHEM.COMPOUND:89992620

subject_name: AVENCIGUAT

object_name: portal hypertension


subject: UNII:ZA7KTB4PSP


subject: CHEBI:26580

subject_name: Rifamycin

object_name: small intestinal bacterial overgrowth


subject: CHEBI:26580

object_name: digestive system infectious disorder


subject: CHEBI:26580

object_name: digestive system disorder


subject: CHEBI:26580

object_name: gastrointestinal disease


subject: PUBCHEM.COMPOUND:2735

subject_name: Provitina

object_name: Accidental Falls


subject: PUBCHEM.COMPOUND:10883523

subject_name: vitamin D3


subject: UMLS:C3265062


subject: CHEBI:27300

subject_name: Ergocalciferol


subject: CHEBI:17698

subject_name: Chloramphenicol

object_name: Childhood Breast Carcinoma


subject: CHEBI:17698

object_name: breast carcinoma


subject: CHEBI:17698

object_name: breast cancer


subject: CHEBI:17698

object_name: Effects of chemotherapy


subject: UNII:H8MTN7XVC2

subject_name: Mitometh


subject: UNII:H8MTN7XVC2


subject: UNII:H8MTN7XVC2


subject: UNII:H8MTN7XVC2


subject: PR:000029794

subject_name: mitochondrial import inner membrane translocase subunit Tim8 A


subject: PR:000029794


subject: PR:000029794


subject: PR:000029794


subject: PUBCHEM.COMPOUND:2767


subject: PUBCHEM.COMPOUND:44424639

subject_name: Vinorelbine


subject: UMLS:C4541385

subject_name: Heplisav-B

object_name: hepatitis B


subject: UNII:C3VX249T6L

subject_name: Ravulizumab

object_name: adult dermatomyositis


subject: UNII:C3VX249T6L

object_name: dermatomyositis


subject: UMLS:C4086207


subject: UMLS:C4086207


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Pancreatic adenocarcinoma metastatic


subject: MESH:C520255

subject_name: 130-nm albumin-bound paclitaxel


subject: MESH:C520255

object_name: Stage IV Pancreatic Cancer AJCC v8


subject: CHEBI:45863

subject_name: Paclitaxel


subject: GTOPDB:9948

subject_name: naptumomab estafenatox

object_name: carcinoma of esophagus


subject: GTOPDB:9948

object_name: esophageal cancer


subject: GTOPDB:9948

object_name: Childhood Esophageal Carcinoma


subject: GTOPDB:9948

object_name: neoplasm of esophagus


subject: GTOPDB:9948

object_name: gastroesophageal cancer


subject: GTOPDB:9948

object_name: endometrial cancer


subject: GTOPDB:9948

object_name: uterine corpus cancer


subject: GTOPDB:9948

object_name: endometrial carcinoma


subject: GTOPDB:9948

object_name: metastatic colorectal cancer


subject: GTOPDB:9948

object_name: prostate carcinoma


subject: GTOPDB:9948

object_name: prostate cancer


subject: GTOPDB:9948

object_name: ovarian cancer


subject: GTOPDB:9948

object_name: ovarian neoplasm


subject: GTOPDB:9948

object_name: ovarian carcinoma


subject: GTOPDB:9948

object_name: bladder tumor


subject: GTOPDB:9948

object_name: urinary bladder carcinoma


subject: GTOPDB:9948

object_name: urinary bladder cancer


subject: GTOPDB:9948

object_name: childhood bladder carcinoma


subject: GTOPDB:9948

object_name: estrogen-receptor positive breast cancer


subject: GTOPDB:9948

object_name: Her2-receptor negative breast cancer


subject: GTOPDB:9948

object_name: triple-negative breast carcinoma


subject: GTOPDB:9948

object_name: Triple-Negative Breast Cancer Finding


subject: GTOPDB:9948

object_name: head and neck squamous cell carcinoma


subject: GTOPDB:9948

object_name: TAF1 Gene Mutation


subject: GTOPDB:9948

object_name: cervical squamous cell carcinoma


subject: GTOPDB:9948

object_name: pancreatic adenocarcinoma


subject: GTOPDB:9948

object_name: nonpapillary renal cell carcinoma


subject: GTOPDB:9948

object_name: clear cell renal carcinoma


subject: GTOPDB:9948

object_name: renal cell adenocarcinoma


subject: GTOPDB:9948

object_name: renal cell carcinoma


subject: GTOPDB:9948

object_name: liver carcinoma


subject: GTOPDB:9948

object_name: Mesothelioma


subject: GTOPDB:9948

object_name: mesothelial neoplasm


subject: GTOPDB:9948

object_name: malignant mesothelioma


subject: GTOPDB:9948

object_name: melanoma


subject: GTOPDB:9948

object_name: non-small cell lung carcinoma


subject: UNII:93T929W6LC

subject_name: NAPTUMOMAB ESTAFENATOX

object_name: carcinoma of esophagus


subject: UNII:93T929W6LC

object_name: esophageal cancer


subject: UNII:93T929W6LC

object_name: Childhood Esophageal Carcinoma


subject: UNII:93T929W6LC

object_name: neoplasm of esophagus


subject: UNII:93T929W6LC

object_name: gastroesophageal cancer


subject: UNII:93T929W6LC

object_name: endometrial cancer


subject: UNII:93T929W6LC

object_name: uterine corpus cancer


subject: UNII:93T929W6LC

object_name: endometrial carcinoma


subject: UNII:93T929W6LC

object_name: metastatic colorectal cancer


subject: UNII:93T929W6LC

object_name: prostate carcinoma


subject: UNII:93T929W6LC

object_name: prostate cancer


subject: UNII:93T929W6LC

object_name: ovarian cancer


subject: UNII:93T929W6LC

object_name: ovarian neoplasm


subject: UNII:93T929W6LC

object_name: ovarian carcinoma


subject: UNII:93T929W6LC

object_name: bladder tumor


subject: UNII:93T929W6LC

object_name: urinary bladder carcinoma


subject: UNII:93T929W6LC

object_name: urinary bladder cancer


subject: UNII:93T929W6LC

object_name: childhood bladder carcinoma


subject: UNII:93T929W6LC

object_name: estrogen-receptor positive breast cancer


subject: UNII:93T929W6LC

object_name: Her2-receptor negative breast cancer


subject: UNII:93T929W6LC

object_name: triple-negative breast carcinoma


subject: UNII:93T929W6LC

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:93T929W6LC

object_name: head and neck squamous cell carcinoma


subject: UNII:93T929W6LC

object_name: TAF1 Gene Mutation


subject: UNII:93T929W6LC

object_name: cervical squamous cell carcinoma


subject: UNII:93T929W6LC

object_name: pancreatic adenocarcinoma


subject: UNII:93T929W6LC

object_name: nonpapillary renal cell carcinoma


subject: UNII:93T929W6LC

object_name: clear cell renal carcinoma


subject: UNII:93T929W6LC

object_name: renal cell adenocarcinoma


subject: UNII:93T929W6LC

object_name: renal cell carcinoma


subject: UNII:93T929W6LC

object_name: liver carcinoma


subject: UNII:93T929W6LC

object_name: Mesothelioma


subject: UNII:93T929W6LC

object_name: mesothelial neoplasm


subject: UNII:93T929W6LC

object_name: malignant mesothelioma


subject: UNII:93T929W6LC

object_name: melanoma


subject: UNII:93T929W6LC

object_name: non-small cell lung carcinoma


subject: UMLS:C1328194

object_name: carcinoma of esophagus


subject: UMLS:C1328194

object_name: esophageal cancer


subject: UMLS:C1328194

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C1328194

object_name: neoplasm of esophagus


subject: UMLS:C1328194

object_name: gastroesophageal cancer


subject: UMLS:C1328194

object_name: endometrial cancer


subject: UMLS:C1328194

object_name: uterine corpus cancer


subject: UMLS:C1328194

object_name: endometrial carcinoma


subject: UMLS:C1328194

object_name: metastatic colorectal cancer


subject: UMLS:C1328194

object_name: prostate carcinoma


subject: UMLS:C1328194

object_name: prostate cancer


subject: UMLS:C1328194

object_name: ovarian cancer


subject: UMLS:C1328194

object_name: ovarian neoplasm


subject: UMLS:C1328194

object_name: ovarian carcinoma


subject: UMLS:C1328194

object_name: bladder tumor


subject: UMLS:C1328194

object_name: urinary bladder carcinoma


subject: UMLS:C1328194

object_name: urinary bladder cancer


subject: UMLS:C1328194

object_name: childhood bladder carcinoma


subject: UMLS:C1328194

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C1328194

object_name: Her2-receptor negative breast cancer


subject: UMLS:C1328194

object_name: triple-negative breast carcinoma


subject: UMLS:C1328194

object_name: Triple-Negative Breast Cancer Finding


subject: UMLS:C1328194

object_name: head and neck squamous cell carcinoma


subject: UMLS:C1328194

object_name: TAF1 Gene Mutation


subject: UMLS:C1328194

object_name: cervical squamous cell carcinoma


subject: UMLS:C1328194

object_name: pancreatic adenocarcinoma


subject: UMLS:C1328194

object_name: nonpapillary renal cell carcinoma


subject: UMLS:C1328194

object_name: clear cell renal carcinoma


subject: UMLS:C1328194

object_name: renal cell adenocarcinoma


subject: UMLS:C1328194

object_name: renal cell carcinoma


subject: UMLS:C1328194

object_name: liver carcinoma


subject: UMLS:C1328194

object_name: Mesothelioma


subject: UMLS:C1328194

object_name: mesothelial neoplasm


subject: UMLS:C1328194

object_name: malignant mesothelioma


subject: UMLS:C1328194

object_name: melanoma


subject: UMLS:C1328194

object_name: non-small cell lung carcinoma


subject: UNII:28X28X9OKV

subject_name: Durvalumab

object_name: gastroesophageal cancer


subject: UNII:28X28X9OKV

object_name: endometrial cancer


subject: UNII:28X28X9OKV

object_name: uterine corpus cancer


subject: UNII:28X28X9OKV

object_name: endometrial carcinoma


subject: UNII:28X28X9OKV

object_name: metastatic colorectal cancer


subject: UNII:28X28X9OKV

object_name: prostate carcinoma


subject: UNII:28X28X9OKV

object_name: prostate cancer


subject: UNII:28X28X9OKV

object_name: ovarian cancer


subject: UNII:28X28X9OKV

object_name: ovarian neoplasm


subject: UNII:28X28X9OKV

object_name: ovarian carcinoma


subject: UNII:28X28X9OKV

object_name: estrogen-receptor positive breast cancer


subject: UNII:28X28X9OKV

object_name: Her2-receptor negative breast cancer


subject: UNII:28X28X9OKV

object_name: head and neck squamous cell carcinoma


subject: UNII:28X28X9OKV

object_name: TAF1 Gene Mutation


subject: UNII:28X28X9OKV

object_name: cervical squamous cell carcinoma


subject: UNII:28X28X9OKV

object_name: pancreatic adenocarcinoma


subject: UNII:28X28X9OKV

object_name: renal cell adenocarcinoma


subject: UNII:28X28X9OKV

object_name: renal cell carcinoma


subject: UNII:28X28X9OKV

object_name: Mesothelioma


subject: UNII:28X28X9OKV

object_name: mesothelial neoplasm


subject: UNII:28X28X9OKV

object_name: malignant mesothelioma


subject: UNII:28X28X9OKV

object_name: melanoma


subject: UNII:28X28X9OKV

object_name: non-small cell lung carcinoma


subject: UMLS:C3641122

object_name: endometrial cancer


subject: UMLS:C3641122

object_name: uterine corpus cancer


subject: UMLS:C3641122

object_name: endometrial carcinoma


subject: UMLS:C3641122

object_name: metastatic colorectal cancer


subject: UMLS:C3641122

object_name: prostate carcinoma


subject: UMLS:C3641122

object_name: prostate cancer


subject: UMLS:C3641122

object_name: ovarian cancer


subject: UMLS:C3641122

object_name: ovarian neoplasm


subject: UMLS:C3641122

object_name: ovarian carcinoma


subject: UMLS:C3641122

object_name: estrogen-receptor positive breast cancer


subject: UMLS:C3641122

object_name: Her2-receptor negative breast cancer


subject: UMLS:C3641122

object_name: head and neck squamous cell carcinoma


subject: UMLS:C3641122

object_name: TAF1 Gene Mutation


subject: UMLS:C3641122

object_name: cervical squamous cell carcinoma


subject: UMLS:C3641122

object_name: renal cell adenocarcinoma


subject: UMLS:C3641122

object_name: renal cell carcinoma


subject: UMLS:C3641122

object_name: Mesothelioma


subject: UMLS:C3641122

object_name: mesothelial neoplasm


subject: UMLS:C3641122

object_name: malignant mesothelioma


subject: UMLS:C3641122

object_name: non-small cell lung carcinoma


subject: UNII:O43472U9X8

subject_name: Obinutuzumab

object_name: carcinoma of esophagus


subject: UNII:O43472U9X8

object_name: esophageal cancer


subject: UNII:O43472U9X8

object_name: Childhood Esophageal Carcinoma


subject: UNII:O43472U9X8

object_name: neoplasm of esophagus


subject: UNII:O43472U9X8

object_name: gastroesophageal cancer


subject: UNII:O43472U9X8

object_name: endometrial cancer


subject: UNII:O43472U9X8

object_name: uterine corpus cancer


subject: UNII:O43472U9X8

object_name: endometrial carcinoma


subject: UNII:O43472U9X8

object_name: metastatic colorectal cancer


subject: UNII:O43472U9X8

object_name: prostate carcinoma


subject: UNII:O43472U9X8

object_name: prostate cancer


subject: UNII:O43472U9X8

object_name: ovarian cancer


subject: UNII:O43472U9X8

object_name: ovarian neoplasm


subject: UNII:O43472U9X8

object_name: ovarian carcinoma


subject: UNII:O43472U9X8

object_name: bladder tumor


subject: UNII:O43472U9X8

object_name: urinary bladder carcinoma


subject: UNII:O43472U9X8

object_name: urinary bladder cancer


subject: UNII:O43472U9X8

object_name: childhood bladder carcinoma


subject: UNII:O43472U9X8

object_name: estrogen-receptor positive breast cancer


subject: UNII:O43472U9X8

object_name: Her2-receptor negative breast cancer


subject: UNII:O43472U9X8

object_name: triple-negative breast carcinoma


subject: UNII:O43472U9X8

object_name: Triple-Negative Breast Cancer Finding


subject: UNII:O43472U9X8

object_name: head and neck squamous cell carcinoma


subject: UNII:O43472U9X8

object_name: TAF1 Gene Mutation


subject: UNII:O43472U9X8

object_name: cervical squamous cell carcinoma


subject: UNII:O43472U9X8

object_name: pancreatic adenocarcinoma


subject: UNII:O43472U9X8

object_name: nonpapillary renal cell carcinoma


subject: UNII:O43472U9X8

object_name: clear cell renal carcinoma


subject: UNII:O43472U9X8

object_name: renal cell adenocarcinoma


subject: UNII:O43472U9X8

object_name: renal cell carcinoma


subject: UNII:O43472U9X8

object_name: liver carcinoma


subject: UNII:O43472U9X8

object_name: Mesothelioma


subject: UNII:O43472U9X8

object_name: mesothelial neoplasm


subject: UNII:O43472U9X8

object_name: malignant mesothelioma


subject: UNII:O43472U9X8

object_name: melanoma


subject: UNII:O43472U9X8

object_name: non-small cell lung carcinoma


subject: RXCUI:1656336

subject_name: sacubitril / valsartan Oral Product

object_name: heart failure


subject: CHEMBL.COMPOUND:CHEMBL1201574

subject_name: ONABOTULINUMTOXINA

object_name: Hyperhidrosis, CTCAE


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Hyperhidrosis


subject: CHEMBL.COMPOUND:CHEMBL1201574

object_name: Residual limbs


subject: UMLS:C0907160

subject_name: Pegylated Interferon Alfa

object_name: adult lymphoma


subject: UMLS:C0907160

object_name: lymphoma


subject: UMLS:C0907160

object_name: pediatric lymphoma


subject: UMLS:C0907160

object_name: small intestine cancer


subject: UMLS:C0907160

object_name: small intestine carcinoma


subject: UMLS:C3892043

subject_name: Ibuprofen Injection

object_name: Post-Operative Pain


subject: CHEBI:77590

subject_name: Armodafinil

object_name: Fatigue, CTCAE 5.0


subject: CHEBI:77590

object_name: Fatigue


subject: CHEBI:35469

subject_name: antidepressant

object_name: psychosis


subject: CHEBI:35469

object_name: Psychotic disorder due to a general medical condition


subject: UMLS:C0003289

subject_name: Antidepressive Agents


subject: UMLS:C0003289


subject: CHEBI:28838

subject_name: Lutein

object_name: Alzheimer disease


subject: CHEBI:27547

subject_name: Zeaxanthin


subject: CHEMBL.COMPOUND:CHEMBL2109527

object_name: osteoarthritis


subject: UNII:TB7D2H7MZZ

object_name: Chronic refractory cough


subject: CHEBI:6427

subject_name: Leuprolide

object_name: prostate neoplasm


subject: UNII:TC549UFL8P

object_name: Chronic liver disease


subject: UNII:TC549UFL8P

object_name: hepatic encephalopathy


subject: UMLS:C1831848


subject: UMLS:C1831848


subject: CHEBI:15372

object_name: phenylketonuria


subject: CHEBI:15372

object_name: classic phenylketonuria


subject: PUBCHEM.COMPOUND:129630809

subject_name: trihydroxybutyrophenone


subject: PUBCHEM.COMPOUND:129630809


subject: CHEBI:173969


subject: CHEBI:173969


subject: CHEBI:59560

subject_name: Sapropterin


subject: CHEBI:59560


subject: UMLS:C4085985

subject_name: sabatolimab

object_name: Myelodysplasia


subject: UMLS:C4329340

subject_name: Nisevokitug


subject: UNII:37CQ2C7X93

subject_name: Canakinumab


subject: UMLS:C2718754

subject_name: Ilaris


subject: UMLS:C0964184

object_name: lung neoplasm


subject: CHEBI:31654

subject_name: gliclazide

object_name: mild neurocognitive disorder


subject: CHEBI:31654

object_name: mild cognitive impairment


subject: CHEBI:201471

subject_name: Prochloraz Metabolite BTS 40348


subject: CHEBI:201471


subject: UNII:21P2M98388

subject_name: Henagliflozin


subject: UNII:21P2M98388


subject: UNII:21P2M98388

object_name: type 2 diabetes mellitus


subject: UMLS:C5543898


subject: CHEBI:41948

subject_name: Eflornithine

object_name: type 1 diabetes mellitus


subject: CHEBI:231601

subject_name: trastuzumab

object_name: Early Stage Breast Carcinoma


subject: UNII:SE2KH7T06F


subject: UMLS:C0338204

subject_name: Herceptin


subject: CHEBI:61397

subject_name: Neratinib


subject: UNII:DO94E28WYW

object_name: myelofibrosis


subject: CHEMBL.COMPOUND:CHEMBL4650418


subject: GTOPDB:13826

subject_name: pegcetacoplan

object_name: C3 glomerulonephritis


subject: GTOPDB:13826


subject: GTOPDB:13826

object_name: Complement 3 Glomerulopathies


subject: GTOPDB:13826

object_name: Dowling-Degos disease 1


subject: GTOPDB:13826

object_name: Dowling-Degos disease


subject: GTOPDB:13826

object_name: dense deposit disease


subject: UNII:TO3JYR3BOU

subject_name: Pegcetacoplan


subject: UNII:TO3JYR3BOU


subject: UNII:TO3JYR3BOU


subject: UNII:TO3JYR3BOU


subject: UNII:TO3JYR3BOU


subject: UNII:TO3JYR3BOU


subject: CHEBI:31859

subject_name: Modafinil

object_name: stroke disorder


subject: CHEBI:31859

object_name: cerebrovascular disorder


subject: CHEBI:31859

object_name: Stroke (heart beat)


subject: CHEBI:31859

object_name: Stroke, CTCAE


subject: UNII:9P1872D4OL

subject_name: Exenatide

object_name: Fatty Liver


subject: UNII:9P1872D4OL

object_name: Androgen excess


subject: CHEBI:8499

subject_name: Propranolol

object_name: Stage III Fallopian Tube Cancer AJCC v7


subject: CHEBI:8499

object_name: Stage IV Primary Peritoneal Cancer AJCC v7


subject: CHEBI:8499

object_name: Stage IIIB Fallopian Tube Cancer AJCC v7


subject: CHEBI:8499

object_name: Stage IIIA Fallopian Tube Cancer AJCC v7


subject: CHEBI:8499

object_name: Stage IIIC Fallopian Tube Cancer AJCC v7


subject: CHEBI:8499

object_name: Stage III Primary Peritoneal Cancer AJCC v7


subject: CHEBI:8499

object_name: Stage IIIB Primary Peritoneal Cancer AJCC v7


subject: CHEBI:8499

object_name: Stage IIIA Primary Peritoneal Cancer AJCC v7


subject: CHEBI:8499

object_name: Stage IIIC Primary Peritoneal Cancer AJCC v7


subject: CHEBI:8499

object_name: Stage II Fallopian Tube Cancer


subject: CHEBI:8499

object_name: Stage IV Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:8499

object_name: Stage IIC Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:8499

object_name: Stage IIA Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:8499

object_name: Stage IIB Fallopian Tube Cancer AJCC v6 and v7


subject: CHEBI:8499

object_name: primary peritoneal serous adenocarcinoma


subject: CHEBI:8499

object_name: peritoneal serous adenocarcinoma


subject: CHEBI:8499

object_name: Stage IV Ovarian Cancer AJCC v6 and v7


subject: CHEBI:8499

object_name: Ovarian epithelial cancer stage II


subject: CHEBI:8499

object_name: Stage IIC Ovarian Cancer AJCC v6 and v7


subject: CHEBI:8499

object_name: Ovarian cancer stage III


subject: CHEBI:8499

object_name: Stage IIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:8499

object_name: Stage IIA Ovarian Cancer AJCC V6 and v7


subject: CHEBI:8499

object_name: fallopian tube clear cell adenocarcinoma


subject: CHEBI:8499

object_name: Stage IIIB Ovarian Cancer AJCC v6 and v7


subject: CHEBI:8499

object_name: Stage IIIA Ovarian Cancer AJCC v6 and v7


subject: CHEBI:8499

object_name: Stage IIIC Ovarian Cancer


subject: CHEBI:8499

object_name: fallopian tube serous adenocarcinoma


subject: CHEBI:8499

object_name: fallopian tube mucinous adenocarcinoma


subject: CHEBI:8499

object_name: Undifferentiated Fallopian Tube Carcinoma


subject: CHEBI:8499

object_name: fallopian tube endometrioid adenocarcinoma


subject: CHEBI:8499

object_name: ovarian clear cell adenocarcinoma


subject: CHEBI:8499

object_name: ovarian serous adenocarcinoma


subject: CHEBI:8499

object_name: ovarian seromucinous carcinoma


subject: CHEBI:8499

object_name: Primary mucinous adenocarcinoma of ovary


subject: CHEBI:8499

object_name: ovarian mucinous adenocarcinoma


subject: CHEBI:8499

object_name: undifferentiated ovarian carcinoma


subject: CHEBI:8499

object_name: ovarian endometrioid adenocarcinoma


subject: CHEBI:51041

subject_name: Acamprosate

object_name: schizoaffective disorder


subject: CHEBI:51041

object_name: schizophrenia 18


subject: CHEBI:134929

subject_name: Nimorazole

object_name: head and neck squamous cell carcinoma


subject: CHEBI:134929

object_name: Hypoxemia


subject: CHEBI:134929

object_name: Hypoxia, CTCAE


subject: GTOPDB:13627

subject_name: zanidatamab

object_name: HER2 protein overexpression


subject: GTOPDB:13627

object_name: non-small cell lung carcinoma


subject: GTOPDB:13627

object_name: salivary gland carcinoma


subject: GTOPDB:13627

object_name: salivary gland cancer


subject: GTOPDB:13627

object_name: gastroesophageal cancer


subject: GTOPDB:13627

object_name: urothelial carcinoma


subject: GTOPDB:13627

object_name: transitional cell carcinoma


subject: GTOPDB:13627

object_name: pancreatic neoplasm


subject: GTOPDB:13627

object_name: exocrine pancreatic carcinoma


subject: GTOPDB:13627

object_name: malignant pancreatic neoplasm


subject: GTOPDB:13627

object_name: endometrial cancer


subject: GTOPDB:13627

object_name: uterine corpus cancer


subject: GTOPDB:13627

object_name: endometrial carcinoma


subject: GTOPDB:13627

object_name: colorectal cancer


subject: GTOPDB:13627

object_name: colorectal carcinoma


subject: GTOPDB:13627

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: GTOPDB:13627

object_name: carcinoma of esophagus


subject: GTOPDB:13627

object_name: esophageal cancer


subject: GTOPDB:13627

object_name: Childhood Esophageal Carcinoma


subject: GTOPDB:13627

object_name: neoplasm of esophagus


subject: GTOPDB:13627

object_name: Stomach cancer


subject: GTOPDB:13627

object_name: gastric cancer


subject: GTOPDB:13627

object_name: ovarian cancer


subject: GTOPDB:13627

object_name: ovarian neoplasm


subject: GTOPDB:13627

object_name: ovarian carcinoma


subject: GTOPDB:13627

object_name: Childhood Breast Carcinoma


subject: GTOPDB:13627

object_name: breast carcinoma


subject: GTOPDB:13627

object_name: breast cancer


subject: UNII:Z20OC92TDI

subject_name: ZANIDATAMAB

object_name: HER2 protein overexpression


subject: UNII:Z20OC92TDI

object_name: non-small cell lung carcinoma


subject: UNII:Z20OC92TDI

object_name: salivary gland carcinoma


subject: UNII:Z20OC92TDI

object_name: salivary gland cancer


subject: UNII:Z20OC92TDI

object_name: gastroesophageal cancer


subject: UNII:Z20OC92TDI

object_name: urothelial carcinoma


subject: UNII:Z20OC92TDI

object_name: transitional cell carcinoma


subject: UNII:Z20OC92TDI

object_name: pancreatic neoplasm


subject: UNII:Z20OC92TDI

object_name: exocrine pancreatic carcinoma


subject: UNII:Z20OC92TDI

object_name: malignant pancreatic neoplasm


subject: UNII:Z20OC92TDI

object_name: endometrial cancer


subject: UNII:Z20OC92TDI

object_name: uterine corpus cancer


subject: UNII:Z20OC92TDI

object_name: endometrial carcinoma


subject: UNII:Z20OC92TDI

object_name: colorectal cancer


subject: UNII:Z20OC92TDI

object_name: colorectal carcinoma


subject: UNII:Z20OC92TDI

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:Z20OC92TDI

object_name: carcinoma of esophagus


subject: UNII:Z20OC92TDI

object_name: esophageal cancer


subject: UNII:Z20OC92TDI

object_name: Childhood Esophageal Carcinoma


subject: UNII:Z20OC92TDI

object_name: neoplasm of esophagus


subject: UNII:Z20OC92TDI

object_name: Stomach cancer


subject: UNII:Z20OC92TDI

object_name: gastric cancer


subject: UNII:Z20OC92TDI

object_name: ovarian cancer


subject: UNII:Z20OC92TDI

object_name: ovarian neoplasm


subject: UNII:Z20OC92TDI

object_name: ovarian carcinoma


subject: UNII:Z20OC92TDI

object_name: Childhood Breast Carcinoma


subject: UNII:Z20OC92TDI

object_name: breast carcinoma


subject: UNII:Z20OC92TDI

object_name: breast cancer


subject: UMLS:C4331966

object_name: HER2 protein overexpression


subject: UMLS:C4331966

object_name: non-small cell lung carcinoma


subject: UMLS:C4331966

object_name: salivary gland carcinoma


subject: UMLS:C4331966

object_name: salivary gland cancer


subject: UMLS:C4331966

object_name: gastroesophageal cancer


subject: UMLS:C4331966

object_name: urothelial carcinoma


subject: UMLS:C4331966

object_name: transitional cell carcinoma


subject: UMLS:C4331966

object_name: pancreatic neoplasm


subject: UMLS:C4331966

object_name: exocrine pancreatic carcinoma


subject: UMLS:C4331966

object_name: malignant pancreatic neoplasm


subject: UMLS:C4331966

object_name: endometrial cancer


subject: UMLS:C4331966

object_name: uterine corpus cancer


subject: UMLS:C4331966

object_name: endometrial carcinoma


subject: UMLS:C4331966

object_name: colorectal cancer


subject: UMLS:C4331966

object_name: colorectal carcinoma


subject: UMLS:C4331966

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UMLS:C4331966

object_name: carcinoma of esophagus


subject: UMLS:C4331966

object_name: esophageal cancer


subject: UMLS:C4331966

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C4331966

object_name: neoplasm of esophagus


subject: UMLS:C4331966

object_name: Stomach cancer


subject: UMLS:C4331966

object_name: gastric cancer


subject: UMLS:C4331966

object_name: ovarian cancer


subject: UMLS:C4331966

object_name: ovarian neoplasm


subject: UMLS:C4331966

object_name: ovarian carcinoma


subject: UMLS:C4331966

object_name: Childhood Breast Carcinoma


subject: UMLS:C4331966

object_name: breast carcinoma


subject: UMLS:C4331966

object_name: breast cancer


subject: UNII:2T1HU6069S

object_name: Prader-Willi syndrome


subject: UMLS:C2715457


subject: UNII:DW94IAT0LS

object_name: cancer


subject: UNII:DW94IAT0LS

object_name: neoplasm


subject: DRUGBANK:DB16596

subject_name: Apple cider vinegar

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:596

subject_name: Cylocide

object_name: Effects of chemotherapy


subject: CHEBI:28680

subject_name: Cytarabine


subject: UMLS:C5200971

subject_name: Decitabine for Injection


subject: UMLS:C5200971

object_name: adult acute myeloid leukemia


subject: CHEBI:145372

subject_name: Gilteritinib


subject: PUBCHEM.COMPOUND:3685


subject: PUBCHEM.COMPOUND:3685


subject: CHEBI:42068

subject_name: Idarubicin


subject: CHEBI:42068


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:133021


subject: CHEBI:3213

subject_name: Bumetanide

object_name: complete trisomy 21


subject: CHEBI:3213

object_name: Down syndrome


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE

object_name: measles


subject: CHEMBL.COMPOUND:CHEMBL2108905

object_name: Adverse reaction to tuberculosis vaccine


subject: CHEMBL.COMPOUND:CHEMBL2108905

object_name: Vaccine-Preventable Diseases


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: UMLS:C0004886


subject: UMLS:C0004886


subject: MESH:D008458

subject_name: Measles Vaccine


subject: MESH:D008458


subject: MESH:D008458


subject: UMLS:C5240001

subject_name: Vaccine product containing only Measles morbillivirus antigen (medicinal product)


subject: UMLS:C5240001


subject: UMLS:C5240001


subject: CHEBI:135918

subject_name: Tucidinostat

object_name: angioimmunoblastic T-cell lymphoma


subject: GTOPDB:12990

subject_name: sintilimab


subject: CHEMBL.COMPOUND:CHEMBL4297829

subject_name: SINTILIMAB


subject: UMLS:C4329335

subject_name: IBI 308


subject: UNII:3A189DH42V

subject_name: Alemtuzumab

object_name: epidermolysis bullosa


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: PUBCHEM.COMPOUND:3367


subject: CHEBI:63599

subject_name: Fludarabine


subject: CHEBI:52993

subject_name: Lormetazepam


subject: CHEBI:6539

subject_name: Lorazepam


subject: UNII:QMS40680K6

subject_name: Palifermin


subject: CHEBI:61057

subject_name: TACROLIMUS


subject: PUBCHEM.COMPOUND:5372


subject: CHEBI:61049

subject_name: Tacrolimus


subject: UMLS:C0700607

subject_name: digoxin antibodies Fab fragments

object_name: hypertension


subject: UMLS:C0700607

object_name: Hypertension, CTCAE


subject: UMLS:C5960007

subject_name: Wee1 Inhibitor APR-1051

object_name: Advanced Malignant Solid Neoplasm


subject: CHEBI:31271

object_name: ulcerative colitis


subject: CHEBI:31271

object_name: inflammatory bowel disease 1


subject: UMLS:C0873019

subject_name: Berberine hydrochloride


subject: UMLS:C0873019


subject: CHEBI:49603

subject_name: Lapatinib

object_name: adult hepatocellular carcinoma


subject: CHEBI:49603

object_name: liver carcinoma


subject: CHEBI:49603

object_name: Unresectable Gallbladder Carcinoma


subject: CHEBI:49603

object_name: Unresectable Extrahepatic Bile Duct Carcinoma


subject: CHEBI:49603

object_name: Localized Non-Resectable Adult Liver Carcinoma


subject: CHEBI:49603

object_name: advanced adult primary liver cancer


subject: CHEBI:49603

object_name: Recurrent Adult Liver Carcinoma


subject: CHEBI:49603

object_name: Recurrent Extrahepatic Bile Duct Carcinoma


subject: CHEBI:49603

object_name: Recurrent Cancer of Gallbladder


subject: CHEBI:49603

object_name: Malignant neoplasm of gallbladder recurrent


subject: CHEBI:85089

subject_name: Ledipasvir

object_name: hepatitis B


subject: CHEBI:85083

subject_name: Sofosbuvir


subject: CHEBI:47612

subject_name: Bezafibrate

object_name: carnitine palmitoyltransferase II deficiency


subject: CHEBI:7773

subject_name: Ondansetron

object_name: post operative nausea and vomiting


subject: CHEBI:91899


subject: CHEBI:3207

subject_name: Budesonide


subject: CHEBI:31236

subject_name: Aripiprazole

object_name: Tourette syndrome


subject: CHEMBL.COMPOUND:CHEMBL2108465

subject_name: GINGER

object_name: type 2 diabetes mellitus


subject: UNII:C5529G5JPQ

subject_name: ginger extract